Purpose: To determine the acute effects of carbohydrate (CHO) ingestion following a bout of maximal eccentric resistance exercise on key anabolic kinases of mammalian target of rapamycin and extracellular signal-regulated kinase (ERK) pathways. The authors’ hypothesis was that the activation of anabolic signaling pathways known to be upregulated by resistance exercise would be further stimulated by the physiological hyperinsulinemia resulting from CHO supplementation. Methods: Ten resistance-trained men were randomized in a crossover, double-blind, placebo (PLA)-controlled manner to ingest either a noncaloric PLA or 3 g/kg of CHO beverage throughout recovery from resistance exercise. Muscle biopsies were collected at rest, immediately after a single bout of intense lower body resistance exercise, and after 3 hr of recovery. Results: CHO ingestion elevated plasma glucose and insulin concentrations throughout recovery compared with PLA ingestion. The ERK pathway (phosphorylation of ERK1/2 [Thr202/Tyr204], RSK [Ser380], and p70S6K [Thr421/Ser424]) was markedly activated immediately after resistance exercise, without any effect of CHO supplementation. The phosphorylation state of AKT (Thr308) was unchanged postexercise in the PLA trial and increased at 3 hr of recovery above resting with ingestion of CHO compared with PLA. Despite stimulating-marked phosphorylation of AKT, CHO ingestion did not enhance resistance exercise–induced phosphorylation of p70S6K (Thr389) and rpS6 (Ser235/236 and Ser240/244). Conclusion: CHO supplementation after resistance exercise and hyperinsulinemia does not influence the ERK pathway nor the mTORC1 target p70S6K and its downstream proteins, despite the increased AKT phosphorylation.
Figueiredo, Cameron-Smith, and Markworth are with Liggins Institute, University of Auckland, Auckland, New Zealand. Farnfield and Gran are with the School of Exercise and Nutrition Sciences, Deakin University, Burwood, Australia. Ross is with the Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. Ross and Halson are with the Sport Science and Sports Medicine, Australian Institute of Sport, Belconnen, Australia. Peake is with Sports Performance Innovation and Knowledge Excellence, Queensland Academy of Sport, Brisbane, Australia, and School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia. Cameron-Smith is with the Food & Bio-Based Products Group, AgResearch, Palmerston North, New Zealand. Markworth is also with the Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.